| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |